Detection of Cytokeratin 19 Mrna in Peripheral Blood by RT-PCR in Patients with Renal Cell Carcinoma

HUANG Jian-hua,HUANG Guo-hua,ZHANG Hai-min,XU Yun-fei,YAN Yang,KONG Xian-guo
DOI: https://doi.org/10.3969/j.issn.1008-0392.2006.01.007
2006-01-01
Abstract:Objective To investigate the expression and clinical significance of cytokeratin 19(CK19) mRNA in peripheral blood in renal cell carcinoma patients.Methods CK19 mRNA in the peripheral blood of 26 patients with renal cell carcinoma and 33 healthy controls was amplified by reverse transcription-polymerase chain reaction(RT-PCR).Results The positive detection rate was 73.1%(19/26) for renal cell carcinorma patients and 21.1%(7/33) for healthy controls.The number of patients expressing CK19 mRNA at each clinical stage was 5 out of 11(45.5%) patients at stage Ⅰ;5 out of 7(71.4%) at stage Ⅱ;4 out of 4(100%) at stage Ⅲ;4 out 4(100%) at stage Ⅳ.A significant difference was seen between healthy controls and renal cell carcinomas by CK19 mRNA expression(P0.01),and also between different clinical stages(P0.05).Conclusion CK19 mRNA may be a useful marker for early detection of renal cell carcinoma and its micrometastasis,and facilitate the design of better therapeutic strategies for the treatment of renal cell carcinoma patients.
What problem does this paper attempt to address?